ArticleThe Lancet. Rheumatology2021
First manifestation of adult-onset Still's disease after COVID-19.
Article in The Lancet. Rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 50 citations in OpenAlex.
- Article
- Characteristics of COVID-19 and Impact of Disease Activity in Patients with Adult-Onset Still's Disease.Rheumatology and therapy · 2024Article
- Association between adult-onset still's disease and COVID-19: A report of two cases and brief review.SAGE open medical case reports · 2024Article
- Evidence of a Sjögren's disease-like phenotype following COVID-19 in mice and humans.JCI insight · 2023Article
- Increased incidence of adult-onset Still's disease in association with COVID-19 vaccination and SARS-CoV-2 infection.Orphanet journal of rare diseases · 2023Article
- Adult-onset Still's disease after SARS-Cov-2 infection.Clinical case reports · 2023Article
- New-onset Adult-onset Still's Disease Following COVID-19 Vaccination: Three Case Reports and a Literature Review.Internal medicine (Tokyo, Japan) · 2023Review
- An Unforeseen Outcome of COVID-19: The Triggering of Adult-Onset Still's Disease.Clinical medicine insights. Arthritis and musculoskeletal disorders · 2023Article
- First report of a patient meeting criteria for both multisystem inflammatory syndrome in children and adult onset Still's disease.BMC rheumatology · 2022Article
- Review
- Evidence of a Sjögren's disease-like phenotype following COVID-19.medRxiv : the preprint server for health sciences · 2022Article
- Reactivation of adult-onset Still's disease after use of the COVID-19 ChAdOx1-S vaccine.BMJ case reports · 2022Article
- Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still's disease.Scientific reports · 2022Article
- Adamalysins in COVID-19 - Potential mechanisms behind exacerbating the disease.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022Review
- Flare of adult-onset Still's disease following mRNA COVID-19 vaccination: a case report and review of literature.Clinical rheumatology · 2022Review
- Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.Frontiers in medicine · 2022Review
- Migration and homeostasis of regulatory T cells in rheumatoid arthritis.Frontiers in immunology · 2022Review
- Progress in Biological Therapies for Adult-Onset Still's Disease.Biologics : targets & therapy · 2022Review
- Article
- Adult-onset Still's Disease after BNT162b2 mRNA COVID-19 Vaccine.Journal of Korean medical science · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.